Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chicago Prostate Cancer Center is a specialized U.S. prostate cancer treatment center focused on diagnosis and radiation-based treatment of prostate cancer, particularly brachytherapy using radioactive seed implants. The center was established in 1997 in Westmont, Illinois, and operates as a for-profit healthcare provider rather than a drug-development biotech or pharma company. Public-facing descriptions emphasize evidence-based treatment planning, advanced diagnostic imaging, and quality-of-life-focused care for men with prostate cancer. In 2019, the center became part of DuPage Medical Group, now Duly Health and Care, and is described as part of the DuPage Medical Group Surgical Center of Westmont. Because it is a clinical care provider, it does not appear to have a traditional therapeutic pipeline, platform, or drug R&D portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prostate Cancer Center.